99 related articles for article (PubMed ID: 3537896)
1. Expression of blood group H antigen by normal, benign, and carcinoma cells of the oral epithelium: immunohistochemical study using monoclonal antibody RS13.
Shabana AH; Lubenko A; Ivanyi L
Oral Surg Oral Med Oral Pathol; 1986 Nov; 62(5):532-7. PubMed ID: 3537896
[TBL] [Abstract][Full Text] [Related]
2. Staining patterns of human pre-malignant oral epithelium and squamous cell carcinomas by monoclonal anti-keratin antibodies.
Reibel J; Clausen H; Dabelsteen E
Acta Pathol Microbiol Immunol Scand A; 1985 Nov; 93(6):323-30. PubMed ID: 2418629
[TBL] [Abstract][Full Text] [Related]
3. Expression of the CA1 determinant by carcinomas and by non-malignant epithelial cells in oral lesions.
Shabana AH; Ivanyi L; Kramer IR
Br J Cancer; 1983 Oct; 48(4):527-31. PubMed ID: 6354238
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical distribution of monoclonal antibodies against keratin in papillomas and carcinomas from oral and nasopharyngeal regions.
Nakai M; Mori M
Oral Surg Oral Med Oral Pathol; 1986 Sep; 62(3):292-302. PubMed ID: 2427988
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies in the diagnosis of epithelial premalignant lesions.
Dabelsteen E; Graem N; Hakomori S; Young WW
Bull Cancer; 1983; 70(2):127-31. PubMed ID: 6871487
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid composition of clinically healthy and malignant oral epithelium.
Macleod RI; Cassidy D; Laker MF; Soames JV
J Oral Pathol Med; 1990 Apr; 19(4):149-51. PubMed ID: 2366201
[TBL] [Abstract][Full Text] [Related]
7. RAS oncogene product expression in normal and malignant oral mucosa.
Freer E; Savage NW; Seymour GJ; Dunn TL; Lavin MF; Gardiner RA
Aust Dent J; 1990 Apr; 35(2):141-6. PubMed ID: 2189381
[TBL] [Abstract][Full Text] [Related]
8. Premalignant and malignant oral lesions are associated with changes in the glycosylation pattern of carbohydrates related to ABH blood group antigens.
Dabelsteen E; Clausen H; Holmstrup P; Reibel J
APMIS; 1988 Sep; 96(9):813-9. PubMed ID: 3048339
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical localization of laminin and its relation to the grade of histological malignancy in oral cancer].
Noguchi M; Kohama G; Hiratsuka H; Miyakawa A; Yamaguchi A; Nagai I; Kyogoku J; Odajima T
Gan No Rinsho; 1989 Jul; 35(8):880-5. PubMed ID: 2746863
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical observations on binding of monoclonal antibody to epithelial membrane antigen in epithelial tumors of the oral cavity and skin.
Tatemoto Y; Saka M; Tanimura T; Mori M
Oral Surg Oral Med Oral Pathol; 1987 Dec; 64(6):721-6. PubMed ID: 2447543
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of a blood group antigen precursor in oral premalignant lesions.
Dabelsteen E; Vedtofte P; Hakomori S; Young WW
Cancer Res; 1983 Mar; 43(3):1451-4. PubMed ID: 6825113
[TBL] [Abstract][Full Text] [Related]
12. Expression of blood group H antigen type 2 chain by oral carcinoma cells after radiotherapy.
Shabana AH; Ivanyi L; Kramer IR
Oral Surg Oral Med Oral Pathol; 1987 Mar; 63(3):340-7. PubMed ID: 3473361
[TBL] [Abstract][Full Text] [Related]
13. Lectin binding to oral squamous carcinoma.
Toto PD; Gargiulo AW
Cancer Detect Prev; 1985; 8(1-2):161-8. PubMed ID: 3905002
[TBL] [Abstract][Full Text] [Related]
14. Histo-blood group ABO antigen in oral potentially malignant lesions and squamous cell carcinoma--genotypic and phenotypic characterization.
Gao S; Bennett EP; Reibel J; Chen X; Christensen ME; Krogdahl A; Dabelsteen E
APMIS; 2004 Jan; 112(1):11-20. PubMed ID: 14961969
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody (G10) to a common antigen of human squamous cell carcinoma: binding of the antibody to the H type 2 blood group determinant.
Kimmel KA; Carey TE; Judd WJ; McClatchey KD
J Natl Cancer Inst; 1986 Jan; 76(1):9-19. PubMed ID: 2416979
[TBL] [Abstract][Full Text] [Related]
16. Quantitation and localization of cellular retinol-binding protein in squamous-cell carcinomas of the cervix uteri and of the oral cavity.
Wahlberg P; Fex G; Biörklund A; Tropé C; Willén R
Int J Cancer; 1988 May; 41(5):771-6. PubMed ID: 3366495
[TBL] [Abstract][Full Text] [Related]
17. Ha-ras oncogene product in human oral squamous cell carcinoma.
Oku N; Shimada K; Itoh H
Kobe J Med Sci; 1989 Dec; 35(5-6):277-86. PubMed ID: 2699627
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of filaggrin in preneoplastic and neoplastic lesions of the human oral mucosa.
Itoiz ME; Conti CJ; Lanfranchi HE; Mamrack M; Klein-Szanto AJ
Am J Pathol; 1985 Jun; 119(3):456-61. PubMed ID: 4014435
[TBL] [Abstract][Full Text] [Related]
19. [The presence of CEA in spinocellular carcinoma of the oral cavity].
Airoldi M; Negri L; Pedani F; Gerbino G; Gandolfo S; Patriarca E
Boll Soc Ital Biol Sper; 1984 Apr; 60(4):871-5. PubMed ID: 6375692
[TBL] [Abstract][Full Text] [Related]
20. Distribution of blood group antigens A, B and H in ameloblastomas.
Vedtofte P; Dabelsteen E
Scand J Dent Res; 1981 Oct; 89(5):424-32. PubMed ID: 7043720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]